Search Results for keywords:"safety"

The Federal Aviation Administration (FAA) is proposing a new rule for Airbus Helicopters Model EC225LP to replace a certain bellcrank in the life raft system to ensure safety. This proposed rule aims to update an existing Airworthiness Directive (AD) from 2019, which required regular inspections, cleaning, and lubrication of the bellcrank. The new rule proposes a replacement of the affected bellcrank with a serviceable part, which would address potential problems where the life raft might not release during an emergency, posing a risk to occupants. The FAA invites the public to submit comments by April 12, 2021.

The Federal Aviation Administration (FAA) has proposed a new airworthiness directive for certain Boeing airplanes, including various DC-10 and MD-10 models. This proposal is due to a reported crack in the pylon aft bulkhead bracket found during an inspection. The directive would require inspections and potential modifications to fix the issue and ensure airplane safety. Comments on the proposal are invited by March 1, 2021, with specific procedures for submitting them provided by the FAA.

The Federal Aviation Administration (FAA) has issued a new airworthiness directive (AD) for certain Boeing 787 models, effective May 2, 2025. This directive, prompted by possible misalignment issues during final assembly of airplane parts, requires inspections of parts on the horizontal stabilizer to ensure safety. The FAA reviewed and addressed public comments, including requests for inspection clarifications and corrections of part numbers. It concluded that the directive is necessary to address potential safety issues related to the airplanes' structural integrity and ensure safe flight and landing.

The Food and Drug Administration (FDA) announced that ETHYOL (amifostine) for injection, 500 mg/vial, was not removed from the market due to safety or effectiveness issues. This ruling implies that the FDA will not take action to revoke approvals for generic versions of this drug and can continue approving such versions if they comply with legal standards. The determination follows a petition and a review of available data, with no evidence found suggesting safety problems. As such, ETHYOL will stay on the "Discontinued Drug Product List" for reasons unrelated to safety or effectiveness.

The Federal Aviation Administration (FAA), part of the Department of Transportation, has issued a final rule requiring remote identification for unmanned aircraft, including drones, in U.S. airspace. This rule addresses safety and security concerns by ensuring that unmanned aircraft provide identification and location information, making it easier to track and manage their operations. The rule outlines three ways for compliance: using a standard remote identification system, utilizing a broadcast module, or operating in specific areas recognized by the FAA. Compliance with this rule becomes mandatory by September 16, 2023, for all unmanned aircraft operations.

Norfolk Southern Corporation has asked the Federal Railroad Administration (FRA) for permission to discontinue or modify a signal system on the Bloomington District of the Midwest Division, between certain mileposts, which include several control points and automatic signals. They plan to switch this segment to a different type of operation because the current system is no longer needed for their operations. The FRA has given the public until April 5, 2021, to share their comments on this proposal through various methods such as online comments, fax, mail, or hand delivery. Comments will help the FRA decide on the petition, although it doesn't expect a public hearing unless requested.

The Federal Aviation Administration (FAA) has proposed a new rule regarding Bombardier, Inc., Model BD-700-1A10 and BD-700-1A11 airplanes due to reports of hydraulic pressure hoses chafing against the aircraft structure, which could cause hydraulic system failures. The rule requires inspections and corrective actions to prevent this issue, and comments on the proposal are open until February 20, 2025. The rule aims to ensure the continued safety of the aircraft by preventing potential hydraulic system leaks and failures that could impact the airplane's operational capabilities.

The Food and Drug Administration (FDA) confirmed that RIOMET, a metformin hydrochloride oral solution, was not taken off the market for safety or effectiveness issues. This finding means that the FDA can continue approving generic versions of this medication if they meet legal requirements. RIOMET is listed as discontinued in the FDA's "Orange Book," but this is not due to any safety concerns. As a result, companies can still seek approval to produce generic versions of RIOMET, provided they comply with all necessary regulations.

The Federal Aviation Administration (FAA) has proposed a new rule regarding specific Boeing 787 airplanes due to concerns that some parts may have been made with the wrong type of titanium alloy, which could impact safety. This proposed rule would require inspections of seat track splice fittings to confirm the material used and take necessary actions if incorrect materials are found. The goal is to prevent potential failures that could affect passenger safety during emergency situations. Public comments on this proposed rule are invited until March 3, 2025.

The Federal Aviation Administration (FAA) has updated an existing airworthiness directive for certain ATR-GIE Avions de Transport Régional airplanes. This update involves adding more restrictive maintenance or inspection requirements to ensure these airplanes remain safe to fly. The decision to supersede the previous rule came after determining that these additional precautions were needed due to potential risks such as fatigue cracking. The FAA aims to tackle these potential safety issues to maintain the structural integrity of the aircraft.